Amaç: Bu araştırma, kanser hastalarında öz bakım yönetiminin ve depresyonun koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-19)] korkusuna etkisi ve ilişkili faktörleri belirlemek amaçlı yürütüldü. Gereç ve Yöntemler: Araştırma, kura yöntemiyle belirlenen toplamda 3 aile sağlığı merkezinde gerçekleşti. Güç analizine göre hesaplanan 197 kişi alınması planlandı, 200 kişi ile araştırma tamamlandı. Araştırmada veri toplama aracı olarak hastaları tanıtıcı anket formu, Koronavirüs Korkusu Ölçeği, Kısa Depresyon Ölçeği, Kronik Hastalıklarda Öz-Bakım Yönetimi Ölçeği kullanıldı. Bulgular: Kanser hastalarında, COVID-19 korkusu üzerine sosyal koruma yönetiminin %10 ile ilk ana etkiye, sosyal koruma yönetimi ve depresyonun %16 ile 2. düzeyde etkiye sahip olduğu belirlendi. Araştırmaya katılanların COVID-19 korku ve depresyon düzeyinin orta, öz bakım yönetimi ve onun alt boyutları olan sosyal ve öz koruma yönetiminin iyi düzeyde olduğu saptandı. Araştırmaya katılan kanser hastalarının COVID-19 korkusu ile öz bakım yönetimi, depresyon, sosyal koruma yönetimi arasında pozitif ilişki belirlendi. Pandemi sürecinde yürütülen bu araştırmada, depresyon düzeyi, hastalık seyrinin kötüye gittiğini bildirenlerde yüksek bulundu (p=0,018). Dördüncü evrede olduğunu bildirenlerde depresyon düzeyi yüksek bulundu (p=0,009). Hastalıklarıyla mücadele gücünün biraz ya da hiç olmadığını bildirenlerin depresyon düzeyinin daha yüksek olduğu belirlendi (p=0,000). Sonuç: Kanser hastalarında sosyal koruma yönetiminin ve depresyonun COVID-19 korkusu üzerinde etkili olduğu bulundu. COVID-19 korkusunun, öz bakım yönetimini ve depresyon düzeyini artırdığı belirlendi. Pandemi sürecinde kanserli hastaların ruh sağlığını korumak ve sosyal koruma yönetimini desteklemek için hemşirelerin koruyucu sağlık ile uygun müdahaleler oluşturması önerilir.
Anahtar Kelimeler: Öz bakım yönetimi; kanser; depresyon; COVID-19 korkusu
Objective: This study was conducted to determine the effects of self-care management and depression on fear of coronavirus disease-2019 (COVID-19) and related factors in cancer patients. Material and Methods: The research was carried out in 3 family health centers determined by lottery method. According to the power analysis, 197 people were planned, research data was completed with 200 people. As data collection tools, patients were collected with an introductory questionnaire, the Coronavirus Fear Scale, the Brief Depression Scale, and the Self-Care Management in Chronic Diseases. Results: Social protection management in cancer patients is the first predictor 10%, social protection management and depression are the 2nd predictors 16%, they have a effect on fear of COVID-19. It was determined that the COVID-19 fear and depression level of the participants in the study was moderate, and self-care management, social and self-protection management, were at a good level. A positive relationship was determined between the fear of COVID-19 and self-care management, depression, social protection management. Depression level was found to be higher in those who reported worsening of the disease course (p=0.018), being in stage 4 (p=0.009), had little or no power to fight their diseases (p=0.000), during the pandemic. Conclusion: Social protection management and depression were found to be effective on fear of COVID-19 in cancer patients. It has been found to increase fear of COVID-19, self-care management, and the level of depression. It is recommended that nurses create appropriate interventions with preventive health to protect the mental health of cancer patients and support social protection management during the pandemic process.
Keywords: Self-care management; cancer; depression; fear of COVID-19
- World Health Organization. Novel Coronavirus (2019-nCoV). Situation Reports. 2020. [Link]
- Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-95. [Crossref] [PubMed] [PMC]
- Slimano F, Baudouin A, Zerbit J, Toulemonde-Deldicque A, Thomas-Schoemann A, Chevrier R, et al. Cancer, immune suppression and coronavirus disease-19 (COVID-19): need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines). Cancer Treat Rev. 2020;88:102063. [Crossref] [PubMed] [PMC]
- Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, et al. A Practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: An International Collaborative Group. Oncologist. 2020;25(6):e936-45. [Crossref] [PubMed] [PMC]
- Hermann B, Lehners N, Brodhun M, Boden K, Hochhaus A, Kochanek M, et al. Influenza virus infections in patients with malignancies -characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO). Eur J Clin Microbiol Infect Dis. 2017;36(3):565-73. [Crossref] [PubMed] [PMC]
- Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-7. [Crossref] [PubMed] [PMC]
- Salako O, Okunade K, Allsop M, Habeebu M, Toye M, Oluyede G, et al. Upheaval in cancer care during the COVID-19 outbreak. Ecancermedicalscience. 2020;14:ed97. [Crossref] [PubMed] [PMC]
- Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020;6(7):1108-10. [Crossref] [PubMed] [PMC]
- Izcovich A, Ragusa MA, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, et al. Prognostic factors for severity and mortality in patients infected with COVID-19: a systematic review. PLoS One. 2020;15(11):e0241955. [Crossref] [PubMed] [PMC]
- Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology. 2020;1-12. [Crossref] [PubMed] [PMC]
- Bandinelli L, Ornell F, von Diemen L, Kessler FHP. The sum of fears in cancer patients inside the context of the COVID-19. Front Psychiatry. 2021;12:557834. [Crossref] [PubMed] [PMC]
- Tsamakis K, Gavriatopoulou M, Schizas D, Stravodimou A, Mougkou A, Tsiptsios D, et al. Oncology during the COVID-19 pandemic: challenges, dilemmas and the psychosocial impact on cancer patients. Oncol Lett. 2020;20(1):441-7. [Crossref] [PubMed] [PMC]
- Cook SA, Salmon P, Hayes G, Byrne A, Fisher PL. Predictors of emotional distress a year or more after diagnosis of cancer: A systematic review of the literature. Psychooncology. 2018;27(3):791-801. [Crossref] [PubMed] [PMC]
- Niedzwiedz CL, Knifton L, Robb KA, Katikireddi SV, Smith DJ. Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC Cancer. 2019;19(1):943. [Crossref] [PubMed] [PMC]
- Hançerlioğlu S, Aykar FŞ. Kronik hastalıklarda Öz-Bakım Yönetimi Ölçeği'nin Türkçe'ye uyarlanması, geçerlik ve güvenirliği [Validity and reliability of Turkish version of the self care management process in chronic illness]. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi. 2018;7(1):175-83. [Link]
- Wang Y, Duan Z, Ma Z, Mao Y, Li X, Wilson A, et al. Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic. Transl Psychiatry. 2020;10(1):263. [Crossref] [PubMed] [PMC]
- Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;(32):57-71. [Crossref] [PubMed]
- Baile WF, Palmer JL, Bruera E, Parker PA. Assessment of palliative care cancer patients' most important concerns. Support Care Cancer. 2011;19(4):475-81. [Crossref] [PubMed]
- Rosenstein DL. Depression and end-of-life care for patients with cancer. Dialogues Clin Neurosci. 2011;13(1):101-8. [Crossref] [PubMed] [PMC]
- van Dongen SI, de Nooijer K, Cramm JM, Francke AL, Oldenmenger WH, Korfage IJ, et al. Self-management of patients with advanced cancer: a systematic review of experiences and attitudes. Palliat Med. 2020;34(2):160-78. [Crossref] [PubMed] [PMC]
- Yıldırım H. Psychosocial status of older adults aged 65 years and over during lockdown in Turkey and their perspectives on the outbreak. Health Soc Care Community. 2022;30(3):899-907. [Crossref] [PubMed]
- Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The Fear of COVID-19 Scale: development and ınitial validation. Int J Ment Health Addict. 2022;20(3):1537-45. [Crossref] [PubMed] [PMC]
- Bakioğlu F, Korkmaz O, Ercan H. Fear of COVID-19 and positivity: mediating role of intolerance of uncertainty, depression, anxiety, and stress. Int J Ment Health Addict. 2021;19(6):2369-82. [Crossref] [PubMed] [PMC]
- Burke WJ, Roccaforte WH, Wengel SP. The short form of the Geriatric Depression Scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol. 1991;4(3):173-8. [Crossref] [PubMed]
- Durmaz B, Soysal P, Ellidokuz H, Isik AT. Validity and reliability of geriatric depression scale-15 (short form) in Turkish older adults. North Clin Istanb. 2018;5(3):216-20. [Crossref] [PubMed] [PMC]
- Huffman DM. Development of an instrumen to measure use of self-care management processes-guarding (SCMP-G). Strickland OL, Diloria C, Editors. Measurement of Nursing Outcomes. 2nd ed. Volume 3: Self Care and Coping. New York: Springer Publishing Company Inc.; 2003. p.150-78. Erişim tarihi: 21.08.2022 Erişim linki: [Link]
- Gencer N. Pandemi sürecinde bireylerin koronavirüs (Kovid-19) korkusu: Çorum örneği [Coronavirus (COVID-19) fear of individuals during the pandemia: Çorum sample]. Uluslararası Sosyal Bilimler Akademi Dergisi. 2020;(4):1153-73. [Crossref]
- Özdin S, Bayrak Özdin Ş. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: the importance of gender. Int J Soc Psychiatry. 2020;66(5):504-11. [Crossref] [PubMed] [PMC]
- Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160-74. [Crossref] [PubMed]
- Aytap F, Özer Z. Kronik hastalığı olan bireylerde depresyon riski ile hastalık öz yönetimi arasındaki ilişki ve etkileyen faktörler [The relationship between risk of depression levels and disease management individuals with chronic diseases and affecting factors]. Turkish Journal of Family Medicine and Primary Care. 2021;15(2):212-22. [Crossref]
- Bäuerle A, Musche V, Schmidt K, Schweda A, Fink M, Weismüller B, et al. Mental health burden of german cancer patients before and after the outbreak of COVID-19: predictors of mental health impairment. Int J Environ Res Public Health. 2021;18(5):2318. [Crossref] [PubMed] [PMC]
- Mohammadpour M, Ghorbani V, Khoramnia S, Ahmadi SM, Ghvami M, Maleki M. Anxiety, self-compassion, gender differences and COVID-19: predicting self-care behaviors and fear of COVID-19 based on anxiety and self-compassion with an emphasis on gender differences. Iran J Psychiatry. 2020;15(3):213-9. [Crossref] [PubMed] [PMC]
- Yousefi Afrashteh M, Masoumi S. Psychological well-being and death anxiety among breast cancer survivors during the Covid-19 pandemic: the mediating role of self-compassion. BMC Womens Health. 2021;21(1):387. [Crossref] [PubMed] [PMC]
.: Process List